Position in QURE
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$199,071
New position
Shares Held
4,322
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#193
of 254 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Derivatives in QURE
reported options exposure · as of Jun 30, 2026CallValue
$4,606
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Secure Asset Management, LLC holds $16,763,477 across 7 Biotechnology names. QURE ranks #5 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORKA |
Oruka Therapeutics, Inc.
|
65,899 | $6,271,607 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
47,105 | $5,514,582 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
78,208 | $4,475,061 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
411 | $204,156 | |
| 5 | QURE |
uniQure N.V.
This page
|
4,322 | $199,071 | |
| 6 | CGEN |
Compugen Ltd
|
40,000 | $85,600 | |
| 7 | MIST |
Milestone Pharmaceuticals Inc.
|
10,000 | $13,400 |
All Filings in QURE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $199,071 | 4,322 | Shares | Sole | 2026-07-15 | |
| 2026-06-30 | $4,606 | 100 | Call | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||